Health ❯Healthcare ❯Clinical Trials

Phase III Trials

Efficacy Studies MDMA Trials MinervaX GBS Vaccine FRESCO-2 Trial Induction Chemotherapy Interlace Trial COMBI-AD Study Weight Loss Efficacy CENTERSTONE Trial Orforglipron Immunological Response BREAKWATER Trial Dietary Interventions ENPP1 Deficiency Treatments OLYMPIA Trials Atezolizumab

8 ARTICLES

last mo.

Anti-Inflammatory Diet and Exercise Associated with Better Survival in Stage III Colon Cancer

Data presented at the 2025 ASCO Annual Meeting show that EDIP-based measures of dietary inflammation influence survival independently of celecoxib use.

5 ARTICLES

last mo.

Atezolizumab-Enhanced Chemotherapy Halves Recurrence in Stage III dMMR Colon Cancer

6 ARTICLES

last mo.

FDA Declines MDMA for PTSD Treatment, Requests Further Trials

Phase III Trials

Anti-Inflammatory Diet and Exercise Associated with Better Survival in Stage III Colon Cancer

Atezolizumab-Enhanced Chemotherapy Halves Recurrence in Stage III dMMR Colon Cancer

Triplet Therapy Doubles Survival in BRAF V600E Metastatic Colorectal Cancer

Moderna’s Combined COVID-19 and Flu Vaccine Shows Promising Phase III Results

Single-Dose Flu Drug Proven to Reduce Household Transmission by 30%

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

New Blood Test Accurately Predicts Melanoma Recurrence in Stage III Patients

New Cervical Cancer Treatment Reduces Death Risk by 40%

FDA Declines MDMA for PTSD Treatment, Requests Further Trials